Lee Rosen

1.2k total citations
6 papers, 297 citations indexed

About

Lee Rosen is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Lee Rosen has authored 6 papers receiving a total of 297 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Hematology. Recurrent topics in Lee Rosen's work include Chronic Lymphocytic Leukemia Research (2 papers), Cancer therapeutics and mechanisms (1 paper) and Acute Myeloid Leukemia Research (1 paper). Lee Rosen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Cancer therapeutics and mechanisms (1 paper) and Acute Myeloid Leukemia Research (1 paper). Lee Rosen collaborates with scholars based in United States, Netherlands and Denmark. Lee Rosen's co-authors include Stuart D. Shumway, Albiruni Ryan Abdul Razak, Li Liang, Raymond W. Lam, Amit M. Oza, Robin M.J.M. van Geel, Anna C. Pavlick, Shelonitda Rose, Raoul Tibes and Jan H.M. Schellens and has published in prestigious journals such as Journal of Clinical Oncology, The Astrophysical Journal and Current Opinion in Hematology.

In The Last Decade

Lee Rosen

6 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lee Rosen United States	6	189	134	36	28	26	6	297
Konstanze von König Germany	5	139 0.7×	58 0.4×	21 0.6×	36 1.3×	34 1.3×	6	397
Sumit Chakraborty India	11	262 1.4×	107 0.8×	8 0.2×	33 1.2×	39 1.5×	24	652
Christine Jelinek United States	10	250 1.3×	48 0.4×	34 0.9×	29 1.0×	23 0.9×	13	450
Matilde Cañelles Spain	12	261 1.4×	124 0.9×	56 1.6×	7 0.3×	28 1.1×	23	567
Audrey Tran United States	8	210 1.1×	41 0.3×	35 1.0×	51 1.8×	37 1.4×	14	446
Mitsuhiro Tachibana Japan	9	72 0.4×	49 0.4×	53 1.5×	88 3.1×	21 0.8×	49	408
Yuriko Uehara Japan	10	471 2.5×	60 0.4×	34 0.9×	58 2.1×	81 3.1×	19	653
L. Dee Nord United States	13	252 1.3×	103 0.8×	13 0.4×	23 0.8×	33 1.3×	27	470
S. Nakai Japan	14	174 0.9×	126 0.9×	4 0.1×	31 1.1×	54 2.1×	45	568
Hao Ning China	14	248 1.3×	62 0.5×	117 3.3×	70 2.5×	131 5.0×	50	534

Countries citing papers authored by Lee Rosen

Since Specialization

Citations

This map shows the geographic impact of Lee Rosen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lee Rosen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lee Rosen more than expected).

Fields of papers citing papers by Lee Rosen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lee Rosen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lee Rosen. The network helps show where Lee Rosen may publish in the future.

Co-authorship network of co-authors of Lee Rosen

This figure shows the co-authorship network connecting the top 25 collaborators of Lee Rosen. A scholar is included among the top collaborators of Lee Rosen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lee Rosen. Lee Rosen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Leijen, Suzanne, Robin M.J.M. van Geel, Anna C. Pavlick, et al.. (2016). Phase I Study Evaluating WEE1 Inhibitor AZD1775 As Monotherapy and in Combination With Gemcitabine, Cisplatin, or Carboplatin in Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 34(36). 4371–4380. 195 indexed citations

2.

Infante, Jeffrey R., Terence Rugg, Michael Gordon, et al.. (2012). Unexpected renal toxicity associated with SGX523, a small molecule inhibitor of MET. Investigational New Drugs. 31(2). 363–369. 35 indexed citations

3.

Jhawer, Minaxi, Lee Rosen, Janet Dancey, et al.. (2006). Phase II trial of nolatrexed dihydrochloride [ThymitaqTM, AG 337] in patients with advanced hepatocellular carcinoma. Investigational New Drugs. 25(1). 85–94. 11 indexed citations

4.

Centola, Michael, et al.. (1996). Production of anti-erythrocyte antibodies by leukemic and nonleukemic b cells in chronic lymphocytic leukemia patients. Leukemia & lymphoma. 20(5-6). 465–469. 9 indexed citations

5.

Rosen, Lee, Robert Vescio, & James R. Berenson. (1995). Multiple myeloma and chronic lymphocytic leukemia. Current Opinion in Hematology. 2(4). 275–282. 6 indexed citations

6.

Fixsen, D. J., E. S. Cheng, D. A. Cottingham, et al.. (1994). Calibration of the COBE FIRAS instrument. The Astrophysical Journal. 420. 457–457. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact